RTN4 and schizophrenia: Regarding the role of Nogo-A in schizophrenia, it is proposed that abnormal Nogo-A expression or NgR mutations may be characterized as genetic risks for neuropsychiatric disorders of presumed neurodevelopmental origin, such as in the case of schizophrenia.